Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medical University of Graz
Age
18–80
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Clinical status of lymph nodes must be available
Sonographical status of lymph nodes must be available
Patients must consent to documentation of cancer treatment
Histologic diagnosis of invasive breast cancer, clinical stage T1-4, M0 (non-inflammatory T4c)
Patients scheduled for neoadjuvant chemotherapy
Treatment with a 3-weekly FEC or AC regimen (3-4 cycles) followed by 3-4 cycles of q3 weekly docetaxel or paclitaxel.
Local HER2 status of tumor biopsy must be negative.
You may not be if
The patient has a prior history of invasive or metastatic breast cancer.
The patient had prior excisional biopsy of the primary invasive breast cancer.
The patient had prior ipsilateral sentinel axillary lymph node biopsy for breast cancer.
The patient cannot safely or feasibly undergo biopsy of the primary tumor.
The patient has a diagnosis of Stage IV (distant metastatic) breast cancer.
The patient has proven HER2-positive breast cancer, defined as a pathology report of amplification of the gene or 3+ score for immunohistochemical staining.
